NCT06034574View on ClinicalTrials.gov

"A Trial Investigating the Accuracy of Continuous Glucose Monitor Systems (Supersapiens Abbott Libre Sense and Dexcom G6) During Exercise in People With Normal Glucose Tolerance"

Not yet recruitingOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Type 1 Diabetes
Interventions
DEVICE

Continuous glucose monitoring

Assessment of accuracy of two different continuous glucose monitoring devices during exercise

Trial Locations (1)

Unknown

Imperial College Clinical Research Facility, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT06034574 - "A Trial Investigating the Accuracy of Continuous Glucose Monitor Systems (Supersapiens Abbott Libre Sense and Dexcom G6) During Exercise in People With Normal Glucose Tolerance" | Biotech Hunter | Biotech Hunter